审稿速度:6.0 | 投稿命中率:50.0
经验分享：周期较长

60 0 举报

登录系统需要验证码

38 0 举报

需要双盲，作者贡献需单独上传

65 0 举报

proof到online要多久，有没有大神回答一下？

146 1 举报

审稿速度:6.0 | 投稿命中率:50.0
偏重的研究方向：肿瘤
经验分享：做个记录，一篇关于罕见转移的临床回顾性研究……
20230306 submitted
0308 Administrative checks complete……

189 11 举报

审稿速度:1.0
偏重的研究方向：肿瘤;长链非编码RNA
经验分享：3/22投稿状态是initial checks; 3/27看状态又变回submitted,这是被拒了吗？

153 1 举报

审稿速度:6.0 | 投稿命中率:50.0
偏重的研究方向：消化道肿瘤;水凝胶
经验分享：我会经常在梅斯上看大家的经验，想着我要是有经验了也来给大家反馈一下，互相帮助共渡毕业大关：
2022-6-21号投稿 Initial Checks，
6-23号更新投稿 Initial Checks，
6-24号Initial checks have been completed and Editor assignment is being determined，
6-27号Editor assessment The Editor is assessing your submission for peer review，
6-30号Reviewer invitation and assignment in process Reviewers are being invited and responses are being received，
7-4号邮件告知UnderReview，Reviewers assigned and awaiting reviewer scores Reviewers have been assigned and are completing reviews，
8-1号Reviewer invitation and assignment in process Reviewers are being invited and responses are being received，
8-15号Reviews returned - awaiting Editor assessment The Editor is considering the reviews and recommendations in order to make decision on your submission，
8-19号通知大修，
9-11号R1修回，
10-24号Reviews returned - awaiting Editor assessment The Editor is considering the reviews and recommendations in order to make decision on your submission，
11-06号催稿信，
12-01号通知二次返修，
12-13号R2修回，
12-22号Accept Admin completing pre-production checks.

299 5 举报

请问这个期刊是必须交版面费吗

163 0 举报

投稿命中率:75.0
偏重的研究方向：肿瘤;长链非编码RNA
经验分享：Received: December 30, 2021;
Revised: June 5, 2022;
Accepted: July 4, 2022
两个审稿人，第一个补了点实验，第二个拒稿。补充实验后再投，没多久就接受了。
没有太多的波折

179 2 举报

Wos到现在去年的没有收录，怎么回事？

218 1 举报